Back to results
US 2001/0056087 A1Published application
Use of 5alpha-androst-1en-3,17-diol to increase the level of the anabolic/androgenic hormone 17beta-hydroxy-5alpha-androst-1-en-3-one in humans
OwnerPatrick Arnoldinventor
Life of this patent
Estimating the term…
Abstract
The invention involves the administration of the natural androgen metabolite 5alpha-androst-1-en-3,17-diol (1-androstenediol) to produce an androgenic and anabolic response in humans. 1-androstenediol behaves as a prohormone in vivo, and converts to the active hormone 17beta-hydroxy-5alpha-androst-1-en-3-one.
Claims8
A method of increasing the 17beta-hydroxy-5alpha-androst-1-en-3-one levels in humans by the administration of an effective amount of 1-androstenediol.
A method of imparting an androgenic/anabolic effect in humans by the administration of an effective amount of 1-androstenediol.
Dependencies are inferred from the claim text.